By using our site, you acknowledge that you have read and understand our Cookie Policy in the Privacy Policy Page.

Category: News

Post

Our Response to Coronavirus

As the outbreak of coronavirus (COVID-19) continues to evolve, FHC has increased our level of awareness and are working to…

Post

Regional Sales Managers, Northeast, Midwest and Southwest Regions

The Regional Sales Manager (RSM),  is accountable for daily sales, design and implementation/execution of tactical plans for the FHC products…

Post

Clinical Application and Sales Specialists, Northeast, Midwest, Southwest and Western regions

The Clinical Applications and Sales Specialist (CASS),  is responsible for all aspects of Procedural and Technical Support and will also…

Post

Accounting Manager

Position: The accounting manager will be responsible for supervising and managing the accounting department and all areas of financial reporting.…

Post

FHC Partners with Neurotargeting to Offer New Solution for Epilepsy Treatment

BOWDOIN, ME – FHC, Inc. and Neurotargeting, LLC have released WayPoint™ Navigator 4.5 planning software, now allowing epileptologists, neurosurgeons, and…

Post

FHC Announces Comprehensive Epilepsy Solutions for Neurosurgery

BOWDOIN, ME – According to the American Epilepsy Society, at least 30-40% of individuals don’t respond to current antiepileptic drugs,…

Post

FHC Awarded 2019 People’s Bank Award

Last night, FHC was awarded the 2019 People’s United Bank Innovation and Technology Award at the 20th annual Maine Family…

Post

Haer named FHC’s Chairman of the Board

FHC, Inc., a global manufacturer of products for the neuroscience industry, is pleased to announce that F. Andrew (Andy) Haer…

Post

FHC Announces FDA Clearance for Guideline 5 System

BOWDOIN, ME – January 8, 2019 – FHC, Inc., announced today that is has received 510(k) clearance from the Food…

Post

FHC products enable use of new surgical technique for Parkinson’s sufferers in Australia

Australia’s 9News recently featured a story about a new surgical approach, using FHC products, that is treating Australian patients affected…